Loading clinical trials...
Loading clinical trials...
Dipeptidyl Peptidase 4 (DPP4) Activity and Its Associations With Endothelial Dysfunction, Inflammatory and Metabolic Markers, Heart Rate and Blood Pressure Variability, and Measures of Adiposity in Subjects With Different Grades of Glucose Tolerance
Conditions
Interventions
Laser-Doppler methods
Start Date
February 1, 2014
Primary Completion Date
December 1, 2015
Completion Date
December 1, 2016
Last Updated
June 8, 2017
NCT07472881
NCT07237750
NCT07460856
NCT07225426
NCT07423780
NCT07445503
Lead Sponsor
Rio de Janeiro State University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions